These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35351252)

  • 1. Clinical effect of different maintenance doses of caffeine citrate in the treatment of preterm infants requiring assisted ventilation: a pilot multicenter study.
    Yang Y; Lu KY; Cheng R; Zhou Q; Fang GD; Li H; Shao J; Wang HY; Li ZY; Liu SL; Li ZG; Cai JL; Xue M; Chen XQ; Pan ZJ; Gao Y; Huang L; Li HY; Song L; Wang SN; Shu GH; Wu W; Yu MZ; Xu Z; Li HX; Xu Y; Bao ZD; Wu XP; Ye L; Dong XP; Yin QG; Yin XP; Zhou JJ;
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Mar; 24(3):240-248. PubMed ID: 35351252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of different maintenance doses of caffeine citrate on ventilator weaning in very preterm infants with respiratory distress syndrome: a prospective randomized controlled trial.
    Li XL; Cai YJ; Zhang Z; Li J; Chen XW; Song YY; Zhou W
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Nov; 23(11):1097-1102. PubMed ID: 34753540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical effect and safety of different maintenance doses of caffeine citrate in treatment of apnea in very low birth weight preterm infants: a prospective randomized controlled trial].
    Zhang X; Zhang HT; Lyu Y; Wang LF; Yang ZY
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jun; 21(6):558-561. PubMed ID: 31208509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical effect of an additional maintenance dose of caffeine before ventilator weaning in preterm infants with respiratory distress syndrome: a prospective randomized controlled trial].
    Yao LS; Lin XZ; Huang J; Tang LX
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Jan; 23(1):31-36. PubMed ID: 33476534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea.
    Kou C; Han D; Li Z; Wu W; Liu Z; Zhang Y; Gao Z
    Minerva Pediatr; 2020 Apr; 72(2):95-100. PubMed ID: 30961342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Safety and efficacy of caffeine use started at different time in preterm infants: a multicenter study in Jiangsu Province, China].
    Yang Y; Cheng R; Wu Q; Qiao LX; Yang ZM; Gu HB; Jiang SY; Liu SL; Jiang SH
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Feb; 22(2):130-135. PubMed ID: 32051079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosing and Safety of Off-label Use of Caffeine Citrate in Premature Infants.
    Puia-Dumitrescu M; Smith PB; Zhao J; Soriano A; Payne EH; Harper B; Bendel-Stenzel E; Moya F; Chhabra R; Ku L; Laughon M; Wade KC;
    J Pediatr; 2019 Aug; 211():27-32.e1. PubMed ID: 31101409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
    Mohammed S; Nour I; Shabaan AE; Shouman B; Abdel-Hady H; Nasef N
    Eur J Pediatr; 2015 Jul; 174(7):949-56. PubMed ID: 25644724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeine citrate maintenance doses effect on extubation and apnea postventilation in preterm infants.
    Wan L; Huang L; Chen P
    Pediatr Pulmonol; 2020 Oct; 55(10):2635-2640. PubMed ID: 32639634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the efficacy of domestic and imported caffeine citrate in the treatment of apnea in preterm infants: a prospective randomized double-blind controlled trial].
    He T; Liao ZC; Ding Y; Wang MJ; Li W; Gan JM; Yue SJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jul; 22(7):684-689. PubMed ID: 32669161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants].
    Zhao Y; Tian X; Liu G
    Zhonghua Er Ke Za Zhi; 2016 Jan; 54(1):33-6. PubMed ID: 26791921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The timing of withdrawal from caffeine citrate in very preterm infants.
    Zhang XF; He XR; Li W; Wang T; Hu JT; Dong QY; Chen PY
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Dec; 23(12):1228-1233. PubMed ID: 34911605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
    Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
    Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic versus therapeutic caffeine for apnea of prematurity: a randomized controlled trial.
    Elmowafi M; Mohsen N; Nour I; Nasef N
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6053-6061. PubMed ID: 33771081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy for Apnoea of Prematurity: A Retrospective Study on Effects of Standard Dose and Genetic Variability on Clinical Response to Caffeine Citrate in Chinese Preterm Infants.
    He X; Qiu JC; Lu KY; Guo HL; Li L; Jia WW; Ni MM; Liu Y; Xu J; Chen F; Cheng R
    Adv Ther; 2021 Jan; 38(1):607-626. PubMed ID: 33180318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Real-World Routine Use of Caffeine Citrate in Preterm Infants: A European Postauthorization Safety Study.
    Lista G; Fabbri L; Polackova R; Kiechl-Kohlendorfer U; Papagaroufalis K; Saenz P; Ferrari F; Lasagna G; Carnielli VP;
    Neonatology; 2016; 109(3):221-7. PubMed ID: 26820884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of caffeine citrate on early pulmonary function in preterm infants with apnea].
    Yu M; Huang JH; Zhu R; Zhang XZ; Wu WY; Wen XH
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Mar; 18(3):206-10. PubMed ID: 26975815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Short-term outcomes and their related risk factors of extremely preterm and extremely low birth weight infants in Guangdong province].
    Collaborative Study Group for Extremely Preterm and Extremely Low Birth Weight Infants
    Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):934-942. PubMed ID: 31795560
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and Safety of Different Maintenance Doses of Caffeine Citrate for Treatment of Apnea in Premature Infants: A Systematic Review and Meta-Analysis.
    Chen J; Jin L; Chen X
    Biomed Res Int; 2018; 2018():9061234. PubMed ID: 30671477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.